Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The broadening therapeutic profile suggests GLP-1 drugs have substantial upside potential beyond current applications
We analyzed clinical data, patient outcomes, and real-world pricing across all five leading GH peptides to determine which one deserves your investment
Discontinuation rates tell a similar story
The LEADER trial (liraglutide) and SUSTAIN-6 trial (semaglutide) demonstrated cardiovascular risk reduction over multi-year follow-up periods (approximately 3.8 years and 2.1 years, respectively)
US$ 20.00
US$ 20.48
US$ 28.21
US$ 21.84
US$ 25.13
US$ 26.43
US$ 22.87
US$ 25.88
US$ 23.28
US$ 26.02
US$ 24.25
US$ 29.32
![Ethan's Typhlosion [DRI - 034/182 - Rare]](http://punkouter.com/cdn/shop/files/630809.jpg?v=1767454732)
